Dave is a managing partner in our Boston office and focuses on investments in healthcare and technology companies. He joined Polaris in 2000 after his first career as an operating executive and entrepreneur.
Previously, he closely partnered and served on the boards of other transformative companies from inception through scaling, including: Archivas (Hitachi), Automattic/WordPress, Bitium (Google), Confluence (TA Associates), CliQr (Cisco), Imprivata (NASDAQ: IMPR, Thoma Bravo), Logentries (Rapid7), LogMeIn (NASDAQ: LOGM), MarkMonitor (Thomson Reuters), Phytel (IBM Watson Health), Q1 Labs (IBM) and vKernel (Dell).
He divides his time between San Francisco, Boston and New York City.
Prior to joining Polaris, Dave was chief operating officer of Calico. During his leadership, the company evolved from startup through IPO with $50 million revenues and $3.5 billion market value. Before that, he was senior vice president of worldwide operations for Pure Atria/Rational Software, a publicly-held market leader acquired by IBM for $2 billion. Earlier, in 12 years with Lotus Development in a number of executive roles including vice president and general manager of sales and services, he helped Lotus to become one of the two largest software companies in the world before it was acquired by IBM for $3.5 billion.
Dave is an Always-On Venture Capital 100 and Venture Capital East 50 recipient and has been named both an Always-On “Cloud Power Player” and “FinTech Power Player.” He’s been a mentor for TechStars, Harvard iLab and IBM SmartCamp, a guest lecturer at Harvard, HBS, and MIT, and a founding member of the Microsoft Advisory Board.
He also serves on the Board of the Dana-Farber Cancer Institute, as well as on their investment committee.
He received a BS from The University of Rhode Island.